We serve Chemical Name:2-(Methylamino)-1,3-thiazole-4-carboxylic acid CAS:1199216-02-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Methylamino)-1,3-thiazole-4-carboxylic acid
CAS.NO:1199216-02-8
Synonyms:F2158-1467;2-(methylamino)thiazole-4-carboxylic acid
Molecular Formula:C5H6N2O2S
Molecular Weight:158.17800
HS Code:2934100090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:90.46000
Exact Mass:158.01500
LogP:0.95600
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like F2158-1467 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(methylamino)thiazole-4-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(methylamino)thiazole-4-carboxylic acid Use and application,F2158-1467 technical grade,usp/ep/jp grade.
Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. 2-(Methylamino)-1,3-thiazole-4-carboxylic acid manufacturer Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections. 2-(Methylamino)-1,3-thiazole-4-carboxylic acid supplier The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. 2-(Methylamino)-1,3-thiazole-4-carboxylic acid vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. 2-(Methylamino)-1,3-thiazole-4-carboxylic acid factory Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.
